VCNX — Vaccinex Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.20m
- $2.78m
- $0.60m
Brief: Vaccinex Announces Clinical Collaboration With Merck
Brief: Vaccinex Files For Common Stock Offering Of Up To $113.0 Mln - SEC Filing
Brief: Vaccinex Announces Appointment Of Robert Scala As Chief Commercial Officer
Brief: Vaccinex Inc Files Prospectus Supplement To Offer And Sell Shares Of Co At An Offering Price Of Up To $13.3 Mln
Brief: Vaccinex Inc Files For Equity Shelf Offering Of 982,184 Shares By Selling Stockholder
Brief: Vaccinex Says Phase 1/2 Trial OF Pepinemab In Alzheimer's Disease To Enrol Patients In Sept
Moves: Former Millennium executive Zaino launches Keystone Capital, eyes biotech
Brief: Vaccinex Intends To Use Net Proceeds From Private Placement To Fund Ongoing Development Of Pepinemab
Brief: Vaccinex Provides Update Of Potentially Pivotal Signal Clinical Trial In Huntington's Disease
Brief: Vaccinex Reports First Quarter 2020 Financial Results And Provides Corporate Update
Vaccinex Inc: Gains as lung cancer therapy shows positive data in early trial
Brief: Vaccinex Says Had Previously Anticipated Beginning Enrollment In Mid-2020 In Study Of Pepinemab In Alzheimer’S Disease - SEC Filing
Brief: Vaccinex Announces Expansion of Pepinemab Development Program To Alzheimer's Disease
Brief: Vaccinex Inc Files For Resale, Of Up To 1.47 Million Of Common Stock By The Selling Stockholders
Brief: Vaccinex Inc Files For Stock Shelf Of Upto $125 Million
Brief: Vaccinex Announces Three Oral Presentations Highlighting Semaphorin 4D
U.S. STOCKS ON THE MOVE-Beyond Meat, health insurers, Nike, vaccine makers
NASDAQ RESUMED AT 11:31 AM
NASDAQ RESUMED AT 11:26 AM